Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Challenge Funds - Challenge Counter Cyclical Fund

+ Add to Watchlist

MEDCHES:ID

8.51 EUR 0.06 0.75%

As of 00:59:30 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Challenge Funds - Challenge Counter Cyclical Fund (MEDCHES)

Year To Date: +17.88% 3-Month: +13.04% 3-Year: +11.00% 52-Week Range: 6.96 - 8.57
1-Month: +3.80% 1-Year: +20.74% 5-Year: +8.04% Beta vs MSGUHC: 0.59

Mutual Fund Chart for MEDCHES

No chart data available.
  • MEDCHES:ID 8.51
  • 1M
  • 1Y
Interactive MEDCHES Chart

Previous Close

Fund Profile & Information for MEDCHES

Challenge Funds - Challenge Counter Cyclical Fund is a UCITS certified open-end fund incorporated in Ireland. The Fund's objective is long-term capital appreciation through investment in a diversified portfolio of leading healthcare or sector related stocks listed or traded on Recognized Exchanges.

Inception Date: 02-28-2001 Telephone: Not Disclosed
Managers: -
Web Site: www.mediolanum.ie

Fundamentals for MEDCHES

NAV (on 2013-05-17) 8.51
Assets (M) (on 2013-05-17) 619.96
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for MEDCHES

No dividends reported

Fees & Expenses for MEDCHES

Front Load 5.00
Back Load -
Current Mgmt Fee 2.15
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MEDCHES

Holding Data Unavailable.

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil